Global pharma & biotech investment activity 2012 — Q2'17 928 874 845 844 751 401 $7.7 $7.0 $9.8 $13.4 $11.7 $6.3 2012 2013 2014 2015 2016 2017* Capital Invested ($B) # of Deals Closed Source: Venture Pulse, Q2'17, Global Analysis of Venture Funding, KPMG Enterprise. *As of 6/30/2017. Data provided by PitchBook,July 13, 2017. As more innovative therapies and targeting of niche audiences combine to draw robust sums of VC invested, pharmaceuticals & biotechnology remains one of the more reliably lucrative sectors, given its unique dynamics of long-term drug pipelines and promising exit avenues via giant strategic acquirers. © 2017 KPMG International Cooperative (“KPMG International”). KPMG International provides no client services and is a Swiss entity with which the independent member firms of the KPMG network are affiliated. #Q2VC